SH2D5 and cancer: SH2D5 expression exhibited positive associations with the drug reactions of Staurosporine, while negative associations with anti-cancer drugs Crizotinib, Tamoxifen, Dolastatin 10, Vinorelbine, Vinblastine, Eribulin mesilate, Homoharringtonine, Tyrothricin (Fig. 7).